2018
DOI: 10.1007/s00580-018-2709-2
|View full text |Cite
|
Sign up to set email alerts
|

Estimation of telomerase, AFP, and AFP-L3 levels in Sudanese patients with hepatocellular carcinoma and chronic liver diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 41 publications
0
1
0
Order By: Relevance
“…In the present study, positive telomerase in ascitic fluid level was significantly increased in MA (81.9%) group IIa and IIb as compared to 31.1% in NMA (group -I). This goes in a way with the work of Rahamtalla et al (24) who studied telomerase activity in the blood and postulated that, telomerase activity was significantly elevated in 70% of patients with HCC and only in 18% of cirrhotic patients.…”
Section: Discussionmentioning
confidence: 60%
“…In the present study, positive telomerase in ascitic fluid level was significantly increased in MA (81.9%) group IIa and IIb as compared to 31.1% in NMA (group -I). This goes in a way with the work of Rahamtalla et al (24) who studied telomerase activity in the blood and postulated that, telomerase activity was significantly elevated in 70% of patients with HCC and only in 18% of cirrhotic patients.…”
Section: Discussionmentioning
confidence: 60%
“…Out of 238 published Case control studies, 95.37% were from Egypt (227 studies), 5 publications from Morocco (350)(351)(352)(353)(354), Single case control study was published from each of Sudan (355), Jordan (356), KSA (357), Syria (358), Tunisia (359) and single shared multicenter study between Tunisia, Morocco and Algeria (360).…”
Section: Case Control Studiesmentioning
confidence: 99%